Related Experiment Video
Updated: Jul 18, 2026

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
Published on: July 8, 2025
Advances in combating fungal diseases: vaccines on the threshold
Jim E Cutler1, George S Deepe, Bruce S Klein
1Department of Pediatrics and Microbiology, Louisiana State University Health Sciences, and Research Institute for Children at Children's Hospital, New Orleans, Louisiana, 70118 USA. jcutler@chnola-research.org
Abstract:
The dramatic increase in fungal diseases in recent years can be attributed to the increased aggressiveness of medical therapy and other human activities. Immunosuppressed patients are at risk of contracting fungal diseases in healthcare settings and from natural environments. Increased prescribing of antifungals has led to the emergence of resistant fungi, resulting in treatment challenges. These concerns, together with the elucidation of the mechanisms of protective immunity against fungal diseases, have renewed interest in the development of vaccines against the mycoses. Most research has used murine models of human disease and, as we review in this article, the knowledge gained from these studies has advanced to the point where the development of vaccines targeting human fungal pathogens is now a realistic and achievable goal.
Insights
Fungal infections are rising due to medical treatments and environmental factors. Research shows that developing vaccines against fungal diseases is now a realistic goal, offering new hope for treatment.
Area of Science:
- Medical Mycology
- Immunology
- Vaccinology
Background:
- Rising incidence of fungal diseases globally.
- Increased risk for immunosuppressed patients in healthcare and natural settings.
- Emergence of antifungal resistance due to increased drug use.
Purpose of the Study:
- To review the current state of vaccine development against human fungal pathogens.
- To highlight the renewed interest in fungal vaccines driven by treatment challenges and immunological insights.
Main Methods:
- Review of existing research, primarily utilizing murine models of human fungal diseases.
- Elucidation of mechanisms of protective immunity against mycoses.
Main Results:
- Significant advancements in understanding protective immunity against fungal pathogens.
- Knowledge gained from preclinical studies indicates feasibility of vaccine development.
Conclusions:
- Vaccine development targeting human fungal pathogens is a realistic and achievable goal.
- Advances in immunology and preclinical models support the transition to clinical applications.
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Antifungal Agents
Vaccinations
Vaccines
Smallpox

